Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day
Status:
Completed
Trial end date:
2018-05-17
Target enrollment:
Participant gender:
Summary
Study Objectives Primary To evaluate the average bioequivalence in healthy volunteers between
medicinal product of Diclofenac Sodium 140mg Medicated Plaster EQI7 in comparison to the
reference medicinal product Flector®, applied once and twice a day.
Secondary To evaluate pharmacokinetic profile on Day 1, adhesivity, local tolerability and
safety of medicinal product Diclofenac Sodium 140mg Medicated Plaster EQI7 in healthy
volunteers in comparison to the reference medicinal product Flector®, applied once and twice
a day.